<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=192888919167017&amp;ev=PageView&amp;noscript=1">
Monday,  June 17 , 2024

Linkedin Pinterest

Tagged Articles:

Just months after public offering, Absci heading for clinical trials with a biologic drug candidate

May 14, 2024, 2:39pm Business

After raising nearly $90 million in its recent public offering, Vancouver-based Absci is advancing toward clinical trials for what would be its first biologic drug candidate. Read story